• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测美国 COVID-19 感染和死亡人数。

Predicting the number of COVID-19 infections and deaths in USA.

机构信息

Department of Software Engineering, University of Malaya, Kuala Lumpur, 50603, Malaysia.

Department of Health Services Policy and Management, Arnold School of Public, Health, Columbia, 29208, SC, United States.

出版信息

Global Health. 2022 Mar 28;18(1):37. doi: 10.1186/s12992-022-00827-3.

DOI:10.1186/s12992-022-00827-3
PMID:35346262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8959784/
Abstract

BACKGROUND

Uncertainties surrounding the 2019 novel coronavirus (COVID-19) remain a major global health challenge and requires attention. Researchers and medical experts have made remarkable efforts to reduce the number of cases and prevent future outbreaks through vaccines and other measures. However, there is little evidence on how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection entropy can be applied in predicting the possible number of infections and deaths. In addition, more studies on how the COVID-19 infection density contributes to the rise in infections are needed. This study demonstrates how the SARS-COV-2 daily infection entropy can be applied in predicting the number of infections within a given period. In addition, the infection density within a given population attributes to an increase in the number of COVID-19 cases and, consequently, the new variants.

RESULTS

Using the COVID-19 initial data reported by Johns Hopkins University, World Health Organization (WHO) and Global Initiative on Sharing All Influenza Data (GISAID), the result shows that the original SAR-COV-2 strain has R<1 with an initial infection growth rate entropy of 9.11 bits for the United States (U.S.). At close proximity, the average infection time for an infected individual to infect others within a susceptible population is approximately 7 minutes. Assuming no vaccines were available, in the U.S., the number of infections could range between 41,220,199 and 82,440,398 in late March 2022 with approximately, 1,211,036 deaths. However, with the available vaccines, nearly 48 Million COVID-19 cases and 706, 437 deaths have been prevented.

CONCLUSION

The proposed technique will contribute to the ongoing investigation of the COVID-19 pandemic and a blueprint to address the uncertainties surrounding the pandemic.

摘要

背景

2019 年新型冠状病毒(COVID-19)带来的不确定性仍是全球主要卫生挑战,需要加以关注。研究人员和医学专家通过疫苗和其他措施,为降低病例数量和预防未来疫情爆发付出了巨大努力。然而,关于严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)感染熵如何应用于预测可能的感染和死亡人数,证据有限。此外,还需要更多研究来了解 COVID-19 感染密度如何导致感染人数增加。本研究展示了如何应用 SARS-CoV-2 日感染熵来预测特定时间段内的感染人数。此外,特定人群内的感染密度会导致 COVID-19 病例增加,进而导致新变种出现。

结果

使用约翰霍普金斯大学、世界卫生组织(WHO)和全球流感共享倡议数据库(GISAID)报告的 COVID-19 初始数据,结果表明原始 SARS-CoV-2 株的 R<1,美国(U.S.)的初始感染增长率熵为 9.11 比特。接近这一数值,受感染者在易感人群中传染他人的平均感染时间约为 7 分钟。假设没有疫苗可用,美国 2022 年 3 月下旬的感染人数可能在 41,220,199 到 82,440,398 之间,死亡人数约为 1,211,036 人。然而,有了可用的疫苗,近 4800 万 COVID-19 病例和 706437 例死亡得到了预防。

结论

该方法将有助于对 COVID-19 大流行的持续调查,并为解决大流行相关不确定性提供蓝图。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2a/8962533/a61b083076ea/12992_2022_827_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2a/8962533/a61b083076ea/12992_2022_827_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2a/8962533/a61b083076ea/12992_2022_827_Fig1_HTML.jpg

相似文献

1
Predicting the number of COVID-19 infections and deaths in USA.预测美国 COVID-19 感染和死亡人数。
Global Health. 2022 Mar 28;18(1):37. doi: 10.1186/s12992-022-00827-3.
2
Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.估算 2021 年 11 月 14 日前全球、区域和国家的 SARS-CoV-2 日感染和累计感染人数:一项统计分析。
Lancet. 2022 Jun 25;399(10344):2351-2380. doi: 10.1016/S0140-6736(22)00484-6. Epub 2022 Apr 8.
3
Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review.长期护理机构中实施的非药物措施以预防 SARS-CoV-2 感染及其后果:快速综述。
Cochrane Database Syst Rev. 2021 Sep 15;9(9):CD015085. doi: 10.1002/14651858.CD015085.pub2.
4
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
5
Travel-related control measures to contain the COVID-19 pandemic: a rapid review.旅行相关的控制措施以遏制 COVID-19 大流行:快速综述。
Cochrane Database Syst Rev. 2020 Oct 5;10:CD013717. doi: 10.1002/14651858.CD013717.
6
Dynamic Public Health Surveillance to Track and Mitigate the US COVID-19 Epidemic: Longitudinal Trend Analysis Study.动态公共卫生监测以追踪和缓解美国新冠疫情:纵向趋势分析研究
J Med Internet Res. 2020 Dec 3;22(12):e24286. doi: 10.2196/24286.
7
The novel zoonotic COVID-19 pandemic: An expected global health concern.新型人畜共患的新冠疫情:一个意料之中的全球卫生问题。
J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671.
8
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
9
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.工作场所干预措施以降低医疗机构外 SARS-CoV-2 感染的风险。
Cochrane Database Syst Rev. 2024 Apr 10;4(4):CD015112. doi: 10.1002/14651858.CD015112.pub3.
10
Physical interventions to interrupt or reduce the spread of respiratory viruses.中断或减少呼吸道病毒传播的物理干预措施。
Cochrane Database Syst Rev. 2020 Nov 20;11(11):CD006207. doi: 10.1002/14651858.CD006207.pub5.

引用本文的文献

1
A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants.一株表达 ACE2 和 TMPRSS2 的新型工程化 A549 细胞系对 SARS-CoV-2,包括德尔塔和奥密克戎变异株高度易感。
Viruses. 2022 Jun 23;14(7):1369. doi: 10.3390/v14071369.
2
Correction: Predicting the number of COVID-19 infections and deaths in USA.更正:预测美国新冠肺炎感染人数和死亡人数。
Global Health. 2022 May 3;18(1):47. doi: 10.1186/s12992-022-00837-1.

本文引用的文献

1
A Predictive Model for the Evolution of COVID-19.一种针对新冠病毒疾病(COVID-19)演变的预测模型。
Trans Indian Natl Acad Eng. 2020;5(2):133-140. doi: 10.1007/s41403-020-00130-w. Epub 2020 Jun 22.
2
Omicron (B.1.1.529 variant of SARS-CoV-2); an emerging threat: Current global scenario.奥密克戎(严重急性呼吸综合征冠状病毒2的B.1.1.529变种);一种新出现的威胁:当前全球形势。
J Med Virol. 2022 May;94(5):1780-1783. doi: 10.1002/jmv.27561. Epub 2022 Jan 5.
3
Covid-19: Hospital admission 50-70% less likely with omicron than delta, but transmission a major concern.
新冠疫情:感染奥密克戎毒株后住院的可能性比感染德尔塔毒株低50%至70%,但传播问题令人深感担忧。
BMJ. 2021 Dec 24;375:n3151. doi: 10.1136/bmj.n3151.
4
Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株的传播事件揭示了多起疫苗突破性感染病例。
BMC Med. 2021 Oct 1;19(1):255. doi: 10.1186/s12916-021-02103-4.
5
SAR-CoV-2 infection, emerging new variants and the role of activation induced cytidine deaminase (AID) in lasting immunity.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染、新出现的变异毒株以及激活诱导胞苷脱氨酶(AID)在持久免疫中的作用。
Saudi Pharm J. 2021 Oct;29(10):1181-1184. doi: 10.1016/j.jsps.2021.09.006. Epub 2021 Sep 20.
6
Confronting the Delta Variant of SARS-CoV-2, Summer 2021.应对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的德尔塔变异株,2021年夏季
JAMA. 2021 Sep 21;326(11):1001-1002. doi: 10.1001/jama.2021.14811.
7
Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses.SARS-CoV-2 病毒的德尔塔和德尔塔+变体的进化分析。
J Autoimmun. 2021 Nov;124:102715. doi: 10.1016/j.jaut.2021.102715. Epub 2021 Aug 11.
8
Novel coronavirus 2019-nCoV (COVID-19): early estimation of epidemiological parameters and epidemic size estimates.新型冠状病毒 2019-nCoV (COVID-19):流行病学参数和疫情规模的早期估计。
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20200265. doi: 10.1098/rstb.2020.0265. Epub 2021 May 31.
9
First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021.2020 年 12 月 14 日至 2021 年 1 月 13 日,COVID-19 疫苗安全监测第一个月-美国。
MMWR Morb Mortal Wkly Rep. 2021 Feb 26;70(8):283-288. doi: 10.15585/mmwr.mm7008e3.
10
Estimating the reproductive number R of SARS-CoV-2 in the United States and eight European countries and implications for vaccination.估计 SARS-CoV-2 在 美国和八个欧洲国家的繁殖数 R 以及对疫苗接种的影响。
J Theor Biol. 2021 May 21;517:110621. doi: 10.1016/j.jtbi.2021.110621. Epub 2021 Feb 13.